A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations

PLoS Neglected Tropical Diseases

Volumn 11, Issue 10, 2017, Pages

  Ofon, Elvis ^a   Noyes, Harry ^b   Mulindwa, Julius ^c   Ilboudo, Hamidou ^d   Simuunza, Martin ^e   Ebo’o, Vincent ^f   Njiokou, Flobert ^g   Koffi, Mathurin ^h   Bucheton, Bruno ^i,j   Fogue, Pythagore ^a   Hertz Fowler, Christiane ^b   MacLeod, Annette ^k   Simo, Gustave ^a  

^a UNIVERSITY OF DSCHANG   (Cameroon)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c MAKERERE UNIVERSITY   (Uganda)

^d Centre International de Recherche Developpement sur lElevage en zone Subhumide Bobo Dioulasso   (Burkina Faso)

^e UNIVERSITY OF ZAMBIA   (Zambia)

^f MINISTRY OF PUBLIC HEALTH   (Cameroon)

^g UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^h Univ Jean Lorougnon Guédé   (Côte d’Ivoire)

ⁱ Institut de recherche pour le développement   (France)

^j Programme National de Lutte contre la Trypanosomose Humaine Africaine   (Guinea)

^k UNIVERSITY OF GLASGOW   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; COMPLEMENT FACTOR H; GAMMA INTERFERON; HAPTOGLOBIN; HLA A ANTIGEN; HLA G ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; HP PROTEIN, HUMAN; HPR PROTEIN, HUMAN; TUMOR ANTIGEN;

ADOLESCENT; ADULT; AFRICAN TRYPANOSOMIASIS; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; HAPTOGLOBIN GENE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASYMPTOMATIC DISEASE; BLOOD; CAMEROON; CHILD; ETHNOLOGY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MIDDLE AGED; NEGLECTED DISEASE; PARASITOLOGY; RISK FACTOR; TRYPANOSOMA BRUCEI GAMBIENSE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTIGENS, NEOPLASM; ASYMPTOMATIC DISEASES; CAMEROON; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEGLECTED DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN; YOUNG ADULT;

EID: 85033435221     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005979     Document Type: Article

References (64)

1. Courtin D, Berthier D, Thevenon S, Dayo G-K, Garcia A, Bucheton B,. (2008). Host genetics in African trypanosomiasis. Infect. Gen. Evol.8:229–238.
2. World Health Organization, (2016). Human African Trypanosomiasis (HAT). Country Leadership and Collaboration on Neglected Tropical Diseases.
3. Jamonneau V, Ilboudo H, Kabore J, Kaba D, Koffi M, Solano P, Garcia A, Courtin D, Laveissiere C, Lingue K, Buscher P, Bucheton B,. (2012). Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl. Trop. Dis. 6, e1691. doi: 10.1371/journal.pntd.0001691 22720107
4. Blackwell J.M., Jamieson S.E., Burgner D,. (2009). HLA and Infectious Diseases. CLIN. MICROBIOL. REV., 22(2) 370–385doi: 10.1128/CMR.00048-08 19366919
5. Carvalho F.M.C., Busser F.D., Freitas V.L.T., Furucho C.R., Sadahiro A., Kono A.S.G, Criado P.R., Moretti L.I, Sato P.K., Shikanai-Yasuda M.A., (2016). Polymorphisms on IFNG, IL12B and IL12RB1 genes and paracoccidioidomycosis in the Brazilian population. Infection, Genetics and Evolution43:245–251. doi: 10.1016/j.meegid.2016.05.025 27223631
6. Francis P.J., Schultz D.W., Hamon S., Ott J., Weleber R.G., Klein M.L., (2007). Haplotypes in the Complement Factor H (CFH) Gene: Associations with Drusen and Advanced Age-Related Macular Degeneration. PLoS ONE2(11): e1197. doi: 10.1371/journal.pone.0001197 18043728
7. Kuhajda F.P., Katumuluwa A.I., Pasternack G.R., (1989). Expression of haptoglobin-related protein and its potential role as a tumor antigen. Proc. Natl. Acad. Sci. 86;1188–1192. 2465547
8. Minang J.T., Gyan B.A., Anchang J.K., Troye-Blomberg M., Perlmann H., Achidi E.A., (2004). Haptoglobin phenotypes and malaria infection in pregnant women at delivery in western Cameroon. Acta Trop. 90, 107–114. 14739029
9. Quaye I.K.E., Ekuban F.A., Goka B.Q., Adabayeri V., Kurtzhals J.A.L., Gyan B., Ankrah N.A., Hviid L., Akanmori B.D., (2000). Haptoglobin 1–1 is associated with susceptibility to severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94:216–219 10897372
10. Santos J.C., Ladeira M.S.P., Pedrazzoli J., Jr.Ribeiro M.L., (2012). Relationship of IL-1 and TNF-á polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population. Braz. J. Med. Biol. Res., 45(9) 811–817. doi: 10.1590/S0100-879X2012007500099 22714811
11. Sortica V.A., Cunha G.M., Ohnishi M.D.O., Souza J.M., Ribeiro-dos-Santos A.K.C., Santos N.P.C., Callegari-Jacques S.M., Santos S.E.B., Hutz M.H., (2012). IL1B, IL4R, IL12RB1 and TNF gene polymorphisms are associated with Plasmodium vivax malaria in Brazil. Malaria Journal (2012), 11:409. doi: 10.1186/1475-2875-11-409 23217179
12. Zhang D-F, Wang D., Li Y-Y., Yao Y-G., (2014). Mapping genetic variants in the CFH gene for association with leprosy in Han Chinese. Genes and Immunity (2014) 15, 506–510; doi: 10.1038/gene.2014.43 25030427
13. Bucheton B, MacLeod A, Jamonneau V,. (2011). Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections. Parasite Immunol33: 438–447. doi: 10.1111/j.1365-3024.2011.01287.x 21385185
14. Courtin D, Milet J., Sabbagh A., Massaro J.D., Castelli E.C., Jamonneau V., Bucheton B., Sese C., Favier B., Rouas-Freiss N., Moreau P., Donadi E.A., Garcia A.,, (2013). HLA-G 30 UTR-2 haplotype is associated with Human African trypanosomiasis susceptibility. Infection, Genetics and Evolution17 (2013) 1–7. doi: 10.1016/j.meegid.2013.03.004 23541412
15. Courtin D, Milet J., Jamonneau V., Yeminanga C.S., Kumeso V.K., Bilengue C.M., Betard C., Garcia A.,, (2007). Association between human African trypanosomiasis and the IL6 gene in a Congolese population. Infect. Genet. Evol. 7, 60–68. doi: 10.1016/j.meegid.2006.04.001 16720107
16. Courtin D., Argiro L., Jamonneau V., N’Dri L., N’Guessan P., Abel L., Dessein A., Cot M., Laveissiere C., Garcia A.,, (2006). Interest of tumor necrosis factor-alpha 308 G/A and interleukin-10 592 C/A polymorphisms in human African trypanosomiasis. Infect. Genet. Evol. 6, 123–129. doi: 10.1016/j.meegid.2005.03.002 15894515
17. Genovese G., Friedman D.J., Ross M.D., Lecordier L., Uzureau P., Freedman B.I., Bowden D.W., Langefeld C.D., Oleksyk T.K., Uscinski Knob A.L., Bernhardy A.J., Hicks P.J., Nelson G.W., Vanhollebeke B., Winkler C.A., Kopp J.B., Pays E., Pollak M.R., (2010). Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science329, 841–845. doi: 10.1126/science.1193032 20647424
18. Hardwick J.R., Menard A., Sironi M., Milet J., Garcia A., C Sese C., Yang F., Fu B., David Courtin D., Hollox E.J., (2014). Haptoglobin (HP) and Haptoglobin-related protein (HPR) copy number variation, natural selection, and trypanosomiasis. Hum. Genet. 133:69–83. doi: 10.1007/s00439-013-1352-x 24005574
19. Ilboudo H., Berthier D., Camara M., Camara O., Kabore J., et al. (2012). APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness. Infect Genet Evol12: 1519–1523. doi: 10.1016/j.meegid.2012.05.010 22691369
20. Lejon V., Lardon J., Kenis G., Pinoges L., Legros D., Bisser S., N’Siesi X., Bosmans E., Buscher P., (2002). Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Trans. R. Soc. Trop. Med. Hyg. 96, 329–333. 12174791
21. Maclean L, Odiit M, Sternberg J.M,. (2006). Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients. Trans R Soc Trop Med Hyg100: 270–275. doi: 10.1016/j.trstmh.2005.03.013 16343570
22. Cooper A, Ilboudo H, Alibu VP, Ravel S, Enyaru J, Weir W, Noyes H, Capewell P, Camara M, Milet J, Jamonneau V, Camara O, Matovu E, Bucheton B, MacLeod A, APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. Elife. 2017May24;6. pii: e25461. doi: 10.7554/eLife.25461 28537557
23. Penchenier L, Grébaut P, Ebo’o Eyenga V, Bodo J.M, Njiokou F, Binzouli J.J, Simarro P, Soula G, Herder S,. (1999). Le foyer de la trypanosomiase humaine africaine de Campo (Cameroun) en 1998. Aspects épidémiologiques, état de l’endémie et comparaison des CATT 1.3 et CATT Latex dans le dépistage de masse. Bull. Soc. Path. Ex. 92, 185–190.
24. Simo G, Mbida J.A, Eyenga V.E, Asonganyi T, Njiokou F, Grébaut P,. (2014). Challenges towards the elimination of Human African trypanosomiasis in the sleeping sickness focus of Campo in southern Cameroon. Parasites Vectors7, 374. doi: 10.1186/1756-3305-7-374 25129168
25. Assonganyi T, Bedifeh B.A, Ade S.S, Ngu J.L,. (1994). An evaluation of the card agglutination test for trypanosomiasis (CATT) reagent in the Fontem sleeping Sickness focus, Cameroon. Afric. J. Med. Med. Sci. 23(1)[39–46].
26. Mélachio T.T., Simo G., Ravel S., De Meeûs T., Causse S., Solano P., Lutumba P., Asonganyi T., Njiokou F., (2011). Population genetics of Glossina palpalis palpalis from central African sleeping sickness foci. Parasites Vectors4, 140. doi: 10.1186/1756-3305-4-140 21767402
27. Simo G, Asonganyi T, Nkinin S.W, Njiokou F, Herder S,. (2006). High prevalence of Trypanosoma brucei gambiense group 1 in pigs from the Fontem sleeping sickness focus in Cameroon. Veterinary Parasitology, 139: 57–66. doi: 10.1016/j.vetpar.2006.02.026 16567049
28. Magnus E, Vervoort T, Van Meirvenne N,. (1978). A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann. Soc. Belg. Méd. Trop. 58: 169–176. 747425.
29. WHO/World Health Organization, 1986. African trypanosomiasis: epidemiology and fight against. Technical Rapport Series, 739, 32pages.
30. Buscher P, Mumba N.D, Kabore J, Lejon V, Robays J, Jamonneau V, Bebronne N, Van der Veken W, Bieler S,. (2009). Improved models of minianion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl. Trop. Dis. 3, e471. doi: 10.1371/journal.pntd.0000471 19936296
31. Jamonneau V, Bucheton B, Kabore J, Ilboudo H, Camara O, et al., (2010). Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa. PLoS Negl. Trop. Dis. 4: e917. doi: 10.1371/journal.pntd.0000917 21200417
32. Zhao J.H, (2007). gap: Genetic Analysis Package. J Stat Softw [Internet]. 2007;23(8):1–18. Available from: http://www.jstatsoft.org/v23/i08
33. MacLean L., Odiit M., Sternberg J.M., (2001). Nitric oxide and cytokine synthesis in human African trypanosomiasis. J. Infect. Dis. 184, 1086–1090doi: 10.1086/323479 11574928
34. MacLean L., Chisi J.E., Odiit M., Gibson W.C., Ferris V., Picozzi K., Sternberg J.M.,, (2004). Severity of Human African Trypanosomiasis inEast Africa is associated with geographic location, parasite genotype and host inflammatory cytokine response profile. Infect. Immun. 72, 7040–7044. doi: 10.1128/IAI.72.12.7040-7044.2004 15557627
35. Maclean L., Odiit M., Macleod A., Morrison L., Sweeney L., Cooper A., Kennedy P.E.G, Sternberg J.M., (2007). Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response. J Infect Dis196: 1620–1628doi: 10.1086/522011 18008245
36. Vasilescu A., Heath S.C., Ivanova R., Hendel H., Do H., Mazoyer A., Khadivpour E., Goutalier F.X., Khalili K., Rappaport J., Lathrop G.M., Matsuda F., Zagury J.F., (2003). Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression. Genes Immun. 4, 441–449. doi: 10.1038/sj.gene.6363983 12944981
37. Ilboudo H, Bras-Goncalves R, Camara M, Flori L, Camara O, Sakande H, Leno M, Petitdidier E, Jamonneau V, Bucheton B,. (2014). Unravelling Human Trypanotolerance: IL8 is Associated with Infection Control whereas IL10 and TNFλ Are Associated with Subsequent Disease Development. PLoS Pathog10(11): e1004469. doi: 10.1371/journal.ppat.1004469 25375156
38. Lajoie J, Hargrove J, Zijenah L.S, Humphrey J.H, Ward B.J, Roge M,. (2006). Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J. Infect. Dis. 193, 298–301. doi: 10.1086/498877 16362895
39. Dias F.C, Castelli E.C, Collares C.V. A, Moreau P, Donadi E.A,. (2015). The role of HLA-G molecule and HLA-G gene polymorphisms in tumors, viral hepatitis, and parasitic diseases. doi: 10.3389/fimmu.2015.00009 25699038
40. Takahashi K, Koga K, Linge H.M, Zhang Y, Lin X, Metz C.N, Al-Abed Y, Ojamaa K, Miller E.J,. (2009). "Macrophage CD74 contributes to MIF-induced pulmonary inflammation". Respir. Res. 10 (1): 33. doi: 10.1186/1465-9921-10-33 PMC 2681459. 19413900.
41. Das R, Mi-Sun K, Kim B.H, Jacob S.T, Subbianc S, Yaoa J, Lin L, Levy R, Murchison C, Burman W.J, Moore C.C, W. Scheld M, David J.R, Kaplan G, MacMicking J.D, Bucala R,. (2013). Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. doi: 10.1073/pnas.1301128110 23882081
42. Jha A.N, Sundaravadivel P, Pati S.S, Patra P.K, Thangaraj K,. (2013). Variations in ncRNA gene LOC284889 and MIF-794CATT repeats are associated with malaria susceptibility in Indian populations. Malar J12: 345. doi: 10.1186/1475-2875-12-345 24066864
43. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M.A.R, Bender D, Maller J, Sklar P, de Bakker P.I.W, Daly M.J, Sham P.C,. (2007). PLINK: a toolset for whole-genome association and population-based linkage analysis. Amer. J. Hum.Genet.81.
44. Ilboudo H, Noyes H, Mulindwa J, Kimuda MP, Koffi M, Kabore JW, et al. (2017). Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis. PLoS Negl Trop Dis11(6): e0005438. doi: 10.1371/journal.pntd.0005438 28570558
45. Semagn K, Babu R, Hearne S, Olsen M,. (2014). Single nucleotide polymorphism genotyping using Kompetitive Allele Specific PCR (KASP): overview of the technology and its application in crop improvement. Molecular Breeding, 33(1), 1–14.
46. Anderson C.A, Pettersson F.H, Clarke G.M, Cardon L.R, Morris A.P, Zondervan K.T,. (2010). Data quality control in genetic-case control association studies. Nat. Protoc. 5:1564–1573. doi: 10.1038/nprot.2010.116 21085122
47. Benjamini Y, Hochberg Y,. (1995): Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society1995:289–300.
48. Van Den Oord E.J.C.G., (2008): Controlling false discoveries in genetic studies. Am. J Med. Genet. B. Neuropsychiatr. Genet. 2008, 147B:637–644.
49. Noyes H.A., Alimohammadian M.H., Agaba M., Brass A., Fuchs H., Gailus-Durner V., et al. (2009). Mechanisms Controlling Anaemia in Trypanosoma congolense Infected Mice. PLoS ONE, 4(4), e5170. doi: 10.1371/journal.pone.0005170 19365556
50. Pays E, Vanhollebeke B,., (2008). Mutual self-defence. The trypanolytic factor story. Microbes Infect. 10, 985–989. doi: 10.1016/j.micinf.2008.07.020 18675374
51. Vanhollebeke B, Pays E,., (2010). The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill. Mol. Microbiol. 76, 806–814. doi: 10.1111/j.1365-2958.2010.07156.x 20398209
52. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan D.P, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van Xong H, Jacquet A, Moguilevsky N, Dieu M, Kane J.P, De Baetselier P, Brasseur R, Pays E,. (2003). Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature422, 83–87. doi: 10.1038/nature01461 12621437
53. Maeda N, McEvoy S.M, Harris H.F, Huisman T, Smithies O,. (1986). Polymorphisms in the human haptoglobin gene cluster: chromosomes with multiple haptoglobin-related (Hpr) genes. Proc Natl Acad Sci83:7395–7399. 2876426
54. MacDonald J.R, Ziman R, Yuen R.K.C, Feuk L, Scherer S.W,. (2013). The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Research, 42(1), 986–992.
55. De Jesus E, Kieft R, Albright B, Stephens N. A, Hajduk S. L,. (2013). A Single Amino Acid Substitution in the Group 1 Trypanosoma brucei gambiense Haptoglobin-Hemoglobin Receptor Abolishes TLF-1 Binding. PLoS Pathogens, 9(4), e1003317. doi: 10.1371/journal.ppat.1003317 23637606
56. Boettger L.M, Rany M, Salem R.M, Handsaker R.E, Peloso G, Kathiresan S, Hirschhorn J, McCarroll S.A,. (2016). Recurring exon deletions in the haptoglobin (HP) gene associate with lower blood cholesterol levels. Nat Genet.; 48(4): 359–366. doi: 10.1038/ng.3510 26901066
57. Bresalier R.S, Byrd J.C, Tessler D, Lebel J, Koomen J, Hawke D, Half E, Liu K.F, Mazurek N,. (2004). A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroent. 127:741–748.
58. Tabak S, Lev A, Valansi C, et al. (1997). "Transcriptionally active haptoglobin-related (Hpr) gene in hepatoma G2 and leukemia molt-4 cells." DNA. Cell Biol. 15 (11): 1001–7. doi: 10.1089/dna.1996.15.1001 8945641
59. Pelak K, Need A.C, Fellay J, Shianna K.V, Feng S, Urban T.J, Ge D, De Luca A, Martinez-Picado J, Wolinsky S.M, Martinson J, Jamieson B, Bream J, Martin M, Borrow P, McMichael A, Haynes B, Telenti A, Carrington M, Goldstein D, Alter G, Immunology NCfHAV. (2011). Copy number variation of KIR genes influences HIV-1 control. PLoS Biology9:e1001208doi: 10.1371/journal.pbio.1001208 22140359
60. Hardwick R.J, Amogne W, Mugusi S, Yimer G, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Janabi M, Machado L.R, Viskaduraki M, Mugusi F, Aderaye G, Lindquist L, Hollox E.J, Aklillu E,. (2012). b-defensin Genomic Copy Number Is Associated With HIV Load and Immune Reconstitution in Sub-Saharan Africans. J Infect Dis206:1012–1019. doi: 10.1093/infdis/jis448 22837491
61. Arnez A.L.E, Venegas E.N, Ober C, Thompson E.E,. (2011). Sequence variation in the IL4 gene and resistance to Trypanosoma cruzi infection in Bolivians. J Allergy Clin Immunol127: 279–282, 282 e271-273. doi: 10.1016/j.jaci.2010.10.026 21211660
62. Florez O, Martin J, Gonzalez C.I,. (2011). Interleukin 4, interleukin 4 receptor-alpha and interleukin 10 gene polymorphisms in Chagas disease. Parasite Immunol33: 506–511. doi: 10.1111/j.1365-3024.2011.01314.x 21729106
63. Hershey G.K, Friedrich M.F, Esswein L.A, Thomas M.L, Chatila T.A,. (1997). The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N. Engl. J. Med. 337 (24): 1720–5. doi: 10.1056/NEJM199712113372403 9392697
64. Kato C.D, Matovu E, Mugasa C.M, Nanteza A, Alibu V.P, (2016). The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness. Allergy Asthma Clin Immunol. 2016;12:1. V. A, C. RD, E. JD, in Essentials of Glycobiolo. doi: 10.1186/s13223-015-0107-8 26734065